Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.53 -0.01 (-1.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) Interest & Investment Income (2018 - 2026)

Updated

Citius Pharmaceuticals' Interest & Investment Income was $116,691 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 465.4% from $20,637 a year earlier and up 117.8% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Interest & Investment Income (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Citius Pharmaceuticals' Interest & Investment Income was $268,795 through Jun 30, 2026, up 54.5% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $110,081, down 85.5% from FY2024.

  • Interest & Investment Income shows a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
  • In earlier fiscal years, Interest & Investment Income was $758,000 in FY2024 (-35.7%), $1.18 million in FY2023 (+369.1%), $251,399 in FY2022 (-4.0%) and $261,825 in FY2021 (+284.7%).
  • The fiscal Q3 2026 figure marks the highest quarterly Interest & Investment Income since fiscal Q4 2024.
  • Compared with a year earlier, Interest & Investment Income has increased for three straight quarters, with growth averaging 59.1% over the last eight quarters.
  • The best year-over-year quarter for Interest & Investment Income over five years was fiscal Q2 2023 (growth of 925.6%); the worst was fiscal Q2 2025 (a decline of 92.6%).
  • Per Business Quant data, CTXR's Interest & Investment Income in the three fiscal quarters before Q3 2026 was $53,584 (Q2 2026), $45,097 (Q1 2026) and $53,423 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Citius Pharmaceuticals 14.55 Mn 23.85 Mn 1.00 Mn 116,691.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116,691.00
Mar 31, 2026 53,584.00
Dec 31, 2025 45,097.00
Sep 30, 2025 53,423.00
Jun 30, 2025 20,637.00
Mar 31, 2025 13,413.00
Dec 31, 2024 22,608.00
Sep 30, 2024 117,314.00
Jun 30, 2024 204,843.00
Mar 31, 2024 182,205.00
Dec 31, 2023 253,638.00
Sep 30, 2023 324,813.00
Jun 30, 2023 336,780.00
Mar 31, 2023 303,275.00
Dec 31, 2022 214,549.00
Sep 30, 2022 134,826.00
Jun 30, 2022 53,020.00
Mar 31, 2022 29,571.00
Dec 31, 2021 33,982.00
Sep 30, 2021 75,601.00
API Access

Citius Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CTXR&period=max&api_key=YOUR_API_KEY